# Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.

> **NCT00174720** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 708 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Ciclesonide (XRP1526)

## Key facts

- **NCT ID:** NCT00174720
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 708 (ACTUAL)
- **Last updated:** 2009-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174720, "Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid.". Retrieved via MORVS 2026-10-22 from https://api.morvs.ai/clinical/NCT00174720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*